Stay updated on Seladelpar in PBC & Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.

Latest updates to the Seladelpar in PBC & Hepatic Impairment Clinical Trial page
- CheckyesterdayChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the ClinicalTrials.gov 403 page, and the displayed site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s site revision identifier advances from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home button, indicating access to the study record is blocked.SummaryDifference22%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a software version update for the page. This update does not modify the study information or how users access the trial data.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision was updated from v3.6.5 to v3.6.6, indicating a small update to the page. It appears to be a maintenance version bump rather than a substantive content change.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC & Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.